Ondine Biomedical, Inc. (GB:OBI) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ondine Biomedical Inc., a Canadian company specializing in light-activated antimicrobial treatments, has announced a C$5 million private placement financing to issue new common shares, aimed at bolstering working capital and supporting commercial growth. The investment, anticipated to close by November 8, 2024, will also complement the company’s recent distribution partnership with Mölnlycke Health Care, enhancing expected sales growth.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.